Next Article in Journal
Is There a Link Between TSH Levels and Schizophrenia? A Systematic Review and Meta-Analysis
Previous Article in Journal
Correlation Between Cardiac Troponin Serum Concentration and Selected Parameters of Subclinical Cardiovascular Dysfunction in Patients With and Without Arterial Hypertension: Retrospective Cross-Sectional Analysis of Real-World Data
Previous Article in Special Issue
Site of Biopsy and Its Accuracy in Preoperative Diagnosis of Superficial Nonampullary Duodenal Epithelial Tumors: Retrospective Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Establishing the Clinical Utility of Glucagon-Enhanced MRCP for Improved Hepatopancreatobiliary Assessment

1
Department of Radiology, Hillel Yaffe Medical Center, Hadera 38100, Israel
2
Technion Israel Institute of Technology, Rappaport Faculty of Medicine, Haifa 3525433, Israel
3
Department of Gastroenterology and Hepatology, Tel Aviv-Sourasky Medical Center, Tel Aviv 64239, Israel
4
Gastroenterology and Hepatology Department, Hillel Yaffe Medical Center, Hadera 38100, Israel
5
Liver Clinic, Clalit Health Services, Nof Haglil 17601, Israel
6
Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311500, Israel
7
Department of Surgery, Carmel Medical Center, Haifa 3436212, Israel
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Clin. Med. 2025, 14(17), 5962; https://doi.org/10.3390/jcm14175962 (registering DOI)
Submission received: 11 July 2025 / Revised: 18 August 2025 / Accepted: 21 August 2025 / Published: 23 August 2025
(This article belongs to the Special Issue Endoscopic Diagnosis and Treatments of Gastrointestinal Diseases)

Abstract

Background: Magnetic Resonance Cholangiopancreatography (MRCP) has continuously evolved to enhance visualization capabilities. However, diagnosing biliary ductal system pathology, particularly early primary sclerosing cholangitis (PSC), remains challenging. This study investigates the influence of intramuscular glucagon (IMG) administration on final image quality and pancreatobiliary ductal system diameter in MRCP. Methods: Forty patients (57.5% female; average age 34.45 ± 8.2) referred for Magnetic Resonance Enterography (MRE) underwent MRCP before and 8–12 min after IMG administration. Two independent MRI specialists analyzed Coronal T2-weighted fast spin-echo high-resolution 3D MRCP images quantitatively and qualitatively. Quantitative assessments involved measuring the transverse diameter of five specific biliary duct structures (inferior, mid, and upper common bile duct; right and left hepatic ducts) and three pancreatic duct segments (head, body, and tail). The qualitative evaluation used a five-point Likert-type scale (1 = perfect visualization; 5 = not visible) for the predefined segments. Interobserver variation was assessed using the Intraclass Correlation Coefficient (ICC). Results: Following IMG administration, the diameters of all corresponding biliary and pancreatic segments significantly increased, with consistently strong interobserver agreement demonstrated pre- and post-IMG administration. Moreover, in qualitative analysis, post-IMG administration scores indicated a significant decrease (p < 0.01) in visualization scores, signifying improved visualization at all corresponding points for both radiologists compared to the pre-glucagon administration scores. The ICC scores pre- and post-IMG administration demonstrated moderate to strong agreement. Conclusions: IMG administration improves MRCP imaging parameters by increasing ductal diameters and enhancing biliary tree visualization, underscoring its potential to detect subtle or early pathological changes.
Keywords: glucagon; magnetic resonance cholangiopancreatography; biliary tree; pancreatobiliary imaging; diagnostic enhancement glucagon; magnetic resonance cholangiopancreatography; biliary tree; pancreatobiliary imaging; diagnostic enhancement

Share and Cite

MDPI and ACS Style

Zeina, A.-R.; Shibolet, O.; Garra, M.; Taher, R.; Gal, O.; Oster, M.; Hazzan, R.; Mahamid, A.; Abu Baker, F. Establishing the Clinical Utility of Glucagon-Enhanced MRCP for Improved Hepatopancreatobiliary Assessment. J. Clin. Med. 2025, 14, 5962. https://doi.org/10.3390/jcm14175962

AMA Style

Zeina A-R, Shibolet O, Garra M, Taher R, Gal O, Oster M, Hazzan R, Mahamid A, Abu Baker F. Establishing the Clinical Utility of Glucagon-Enhanced MRCP for Improved Hepatopancreatobiliary Assessment. Journal of Clinical Medicine. 2025; 14(17):5962. https://doi.org/10.3390/jcm14175962

Chicago/Turabian Style

Zeina, Abdel-Rauf, Oren Shibolet, Mohamed Garra, Randa Taher, Oren Gal, Michael Oster, Rawi Hazzan, Ahmad Mahamid, and Fadi Abu Baker. 2025. "Establishing the Clinical Utility of Glucagon-Enhanced MRCP for Improved Hepatopancreatobiliary Assessment" Journal of Clinical Medicine 14, no. 17: 5962. https://doi.org/10.3390/jcm14175962

APA Style

Zeina, A.-R., Shibolet, O., Garra, M., Taher, R., Gal, O., Oster, M., Hazzan, R., Mahamid, A., & Abu Baker, F. (2025). Establishing the Clinical Utility of Glucagon-Enhanced MRCP for Improved Hepatopancreatobiliary Assessment. Journal of Clinical Medicine, 14(17), 5962. https://doi.org/10.3390/jcm14175962

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop